Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Assessment of gastric emptying rate to explore mechanisms of satiety and reduced food intake

The inhibition of gastric emptying has been linked to satiety and reduced food intake. We offer direct (phenol red recovery) and indirect (serum APAP) models of gastric emptying, depending on your project requirements. This allows the ability of drugs to inhibit gastric emptying to be evaluated. Both models have been validated using the clinical opioid agonist loperamide,  which decreased gastric emptying compared to control animals.

Loperamide Inhibits gastric emptying in a dose-dependent manner in mice (measured directly using the Phenol Red method)

Loperamide Inhibits gastric emptying in a dose-dependent manner in mice (measured indirectly using the serum APAP method)

We also provide a solid food model to investigate the ability of drugs to inhibit gastric emptying.

Get in touch for more information or browse our models of metabolic disorders.

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.